EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Linagliptin Renoprotective Role in Rats with Cisplatin-induced Nephrotoxicity

Abeer T. Watife, Ahsan F. Bairam, Nibras H. Abdulsada

Medical Journal of Babylon · 2026-01 · 23 (1) · 152-158

DOI: 10.4103/mjbl.mjbl_860_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Journal of Babylon, online erschienen am 30.04.2026. Verfasst von Abeer T. Watife und 2 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nephrotoxicity is a common type of toxicity associated with the use of many chemotherapeutic agents, especially cisplatin. The prevalence of cisplatin nephrotoxicity is about 28% to 36% after a single dose. Cisplatin is an important agent for treating a wide range of solid tumors, so nephroprotection is very important. Linagliptin is an antidiabetic drug that acts by inhibiting the enzyme dipeptidyl peptidase-4. This group of drugs has pleiotropic effects that may reduce nephrotoxicity caused by cisplatin.

Objectives

To evaluate the nephroprotective effect of linagliptin against cisplatin-induced nephrotoxicity. Materials and Methods: A total of 28 male rats were divided into four groups: control, cisplatin alone, cisplatin with linagliptin, and linagliptin alone. The rats were administered cisplatin (7 mg/kg, IP single dose on day 8) alone or in combination with linagliptin (3 mg/kg/day, orally for 14 days) and the control group received only distal water. After 2 weeks, blood samples were collected for measurement of tumor necrotic factor- α , caspase-3, total antioxidant capacity, urea, and creatinine. Animals were then sacrificed and the kidney was removed for histopathological studies. Data are expressed as the mean ± standard error of the mean.

Results

Linagliptin treatment significantly minimized cisplatin-induced nephrotoxicity and improved kidney function by reducing serum urea, creatinine, caspase-3, and TNF- α levels and increasing serum total antioxidant capacity level. In addition, linagliptin improved histopathological changes induced by cisplatin administration.

Conclusion

Linagliptin may serve as a nephron-protectant when administered concomitantly with cisplatin.

Zitieren

APA

Watife, A. T., Bairam, A. F., & Abdulsada, N. H. (2026). Linagliptin Renoprotective Role in Rats with Cisplatin-induced Nephrotoxicity. Medical Journal of Babylon, 23(1), 152-158. https://doi.org/10.4103/mjbl.mjbl_860_23

Vancouver

Watife AT, Bairam AF, Abdulsada NH. Linagliptin Renoprotective Role in Rats with Cisplatin-induced Nephrotoxicity. Medical Journal of Babylon. 2026;23(1):152-158. doi:10.4103/mjbl.mjbl_860_23

BibTeX
@article{Watife2026,
  author = {Watife, Abeer T. and Bairam, Ahsan F. and Abdulsada, Nibras H.},
  title = {Linagliptin Renoprotective Role in Rats with Cisplatin-induced Nephrotoxicity},
  journal = {Medical Journal of Babylon},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {152--158},
  doi = {10.4103/mjbl.mjbl_860_23}
}
Kostenlos starten →